Experimental group:Neoadjuvant immunotherapy combined with chemotherapy

3 trials

Sponsors

Shanghai Chest Hospital, China-Japan Friendship Hospital, Institute of Clinical Pharmacology, Xiangya Hospita Central South University

Conditions

Esophageal CancerNon-small cell lung cancerNon-small cell lung cancer (NSCLC)

Early Phase 1

Comparison of neodajuvant chemoradiation and neodajuvant chemotherapy combined with immunotherapy treating locally advanced esophageal squamous cell carcinoma: a multi-center randomized open clinical trial

Active, not recruitingChiCTR2000035609

Shanghai Chest HospitalEsophageal Cancer

Start: 2020-10-01Updated: 2020-08-31

Clinical study of immunotherapy combined with chemotherapy for postoperative adjuvant therapy of stage II-IIIA non-small cell lung cancer

Active, not recruitingChiCTR2100050439

China-Japan Friendship HospitalNon-small cell lung cancer (NSCLC)

Start: 2021-10-11Updated: 2022-05-02

A clinical study on evaluating the efficacy of neoadjuvant immunotherapy combined with chemotherapy in patients with potentially/resectable non-small cell lung cancer

RecruitingChiCTR2200057840

Institute of Clinical Pharmacology, Xiangya Hospita Central South UniversityNon-small cell lung cancer

Start: 2021-04-16Updated: 2023-11-13